Becker Business Podcast:

“Signs of Optimism in Healthcare Private Equity”

Guest: Amber Walsh (McGuireWoods LLP)
Host: Scott Becker
Release Date: October 10, 2025

Episode Overview

This episode explores the current state and future outlook of the healthcare private equity (PE) space, with Amber Walsh—partner at McGuireWoods LLP and specialist at the intersection of health care and private equity—joining Scott Becker to break down recent trends, deal data, and market sentiment. The discussion centers on deal volumes, the influence of macroeconomic factors (particularly interest rates), and signs of cautious optimism for the remainder of the year.

Key Discussion Points & Insights

1. State of the Private Equity Deal Market

[00:00–02:45]

• Recent Deal Activity:
  Amber notes that Q3 data is out quickly (<48 hours after quarter-end) from sources like PitchBook and Bain.

  • “What is reported by these deal aggregators… feels pretty consistent with what I am personally experiencing and what we are experiencing within the healthcare private equity team at McGuireWoods.” (Amber Walsh, 01:20)

• Deal Volume & Size:

  • Number of deals is down, both broadly in PE and in healthcare specifically.
  • However, the total dollars invested is up—mostly driven by large, “mega-sized” deals.
  • Indicates rising participation by large funds, while smaller deals requiring debt financing remain challenged by high interest rates.

• Interest Rates & Market Caution:

  • Until late Q3, “there was still a little bit of caution” due to interest rates not yet declining.
  • The market has shown more appetite for big, well-capitalized investments over smaller, debt-heavy ones.
  • As interest rates have recently dropped, more deals are expected in Q4, boosting optimism.

2. Exits, Bolt-Ons, and ‘Dry Powder’

[03:10–05:36]

• Exit Market:

  • Conversations about “trillions of dollars ready for exits” have persisted, but many exits have been delayed, particularly where investor valuation expectations aren’t met.

  • Some paused or stalled deals are coming back to market, encouraged by improved debt terms.

  • “With the availability of less expensive debt financing, maybe you’re going to be able to actually put those dollars to use and execute upon those exits.” (Amber Walsh, 04:23)

• Cautious Optimism:

  • Despite dry powder, some participants are in “wait and see mode.”
  • Operational improvements, efficiency goals, and investment in AI continue to be a focus—as firms aren’t abandoning organic or operational growth just because exits are looking marginally more achievable.
  • “We’re not just going to put those [operational improvements] to the side simply because we think we might have kind of a slow turnaround in the market.” (Amber Walsh, 05:18)

3. Operational Focus & Market Segmentation

[05:36–06:46]

• Operational Improvements:

  • Many are prioritizing balance sheet stability, ensuring companies aren’t over-leveraged, and focusing on operational efficiencies.
  • Lower margin businesses with significant debt are seeing more challenges, but industry-wide panic is not prevalent.

• Segments in Recovery:

  • Mega-deals (“the Blackstones of the world… they are in the business and they’re going to do deals regardless” – Scott Becker, 06:07) have already returned.
  • Small and mid-sized deals are recovering more slowly but are also showing progress.

• Overall Sentiment:

  • The tone is one of “reasonably steady” activity with “a lot of hopefulness towards improved deal volume both on the bolt on side and on the exit side.” (Scott Becker, 06:05)

Notable Quotes & Memorable Moments

• Amber Walsh [01:20]:
  “What is reported by these deal aggregators… feels pretty consistent with what I am personally experiencing and what we are experiencing within the healthcare private equity team at McGuireWoods.”

• Amber Walsh [04:23]:
  “With the availability of less expensive debt financing, maybe you’re going to be able to actually put those dollars to use and execute upon those exits.”

• Amber Walsh [05:18]:
  “We’re not just going to put those [operational improvements] to the side simply because we think we might have kind of a slow turnaround in the market.”

• Scott Becker [06:07]:
  “…the Blackstones of the world, they are in the business and they’re going to do deals regardless…”

Timestamps for Important Segments

• [00:00–01:20] – Introduction & Amber’s market overview
• [01:20–02:45] – Deal volume vs. deal size trend explanations
• [03:10–04:40] – Stalled exits, dry powder, and renewed activity with better financing
• [04:40–05:36] – Market optimism and ongoing focus on operational excellence
• [05:36–06:40] – Operational risk in lower margin, high debt businesses & market segmentation
• [06:40–06:46] – Closing acknowledgements

Summary

Amber Walsh offers a cautiously optimistic assessment of healthcare private equity as 2025 closes out. While the number of deals remains below “normal” levels, the size of completed transactions suggests continued confidence from large investors. The declining cost of debt is encouraging previously delayed exits to return, though operational and structural improvements remain a parallel and ongoing focus. Mega-deals have rebounded first, small/midsize activity is building gradually, and actors across the market are positioning for increased activity into year-end and beyond.

Listeners come away with a nuanced understanding: there remains both challenge and substantial opportunity in this pivotal, evolving sector.